` 500124 (Dr Reddy's Laboratories Ltd) vs APN (Aspen Pharmacare Holdings Ltd) Comparison - Alpha Spread

500124
vs
A
APN

Over the past 12 months, DRREDDY has significantly outperformed APN, delivering a return of +3% compared to the APN's 17% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
500124
APN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

DRREDDY Intrinsic Value
1 067.8 INR
Overvaluation 12%
Intrinsic Value
Price ₹1 218.3
A
APN Intrinsic Value
18 534.03 Zac
Undervaluation 28%
Intrinsic Value
Price Zac13 339
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Dr Reddy's Laboratories Ltd
BSE:500124
1 218.3 INR
A
Aspen Pharmacare Holdings Ltd
JSE:APN
13 339 Zac
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
500124, APN

500124
APN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Dr Reddy's Laboratories Ltd
Revenue
A
Aspen Pharmacare Holdings Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
500124, APN

500124
APN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Dr Reddy's Laboratories Ltd
BSE:500124
A
Aspen Pharmacare Holdings Ltd
JSE:APN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

DRREDDY
65.8%
APN
41.9%

Operating Margin

DRREDDY
18.2%
APN
-1.7%

Net Margin

DRREDDY
16.1%
APN
-5.2%

FCF Margin

DRREDDY
5.3%
APN
0.6%

ROE

DRREDDY
16.7%
APN
-2.4%

ROA

DRREDDY
11%
APN
-1.5%

ROIC

DRREDDY
12.1%
APN
-0.7%

ROCE

DRREDDY
17.3%
APN
-0.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
500124, APN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
500124, APN

Loading
500124
APN
Difference
www.alphaspread.com

Performance By Year
500124, APN

Loading
500124
APN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 500124 to other stocks
LLY
Eli Lilly and Co
More expensive
vs DRREDDY
JNJ
Johnson & Johnson
More expensive
vs DRREDDY
ROG
Roche Holding AG
Cheaper
vs DRREDDY
AZN
AstraZeneca PLC
More expensive
vs DRREDDY
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett